Nanoscope Therapeutics Announces Presentations at the ARVO A

/PRNewswire/ -- Nanoscope Therapeutics Inc., a late-stage clinical biotechnology company developing gene therapies for retinal degenerative diseases, today...

Related Keywords

Dallas , Texas , United States , Subrata Batabyal , Najam Sharif , Vinitb Mahajan , Samarendra Mohanty , Samuel Barone , Nanoscope Therapeutics Inc , Prnewswire Nanoscope Therapeutics Inc , Professor Of Ophthalmology At Stanford University , Seattle Convention Center , Clinical Development , Global Research , Therapeutics Inc , Multi Characteristic Opsin , Nanoscope Therapeutics , Convention Center , Chief Medical , Test Retest Agreement , Freiburg Visual Acuity Test , Poster Number , Low Vision Performance , Exhibit Hall , Stargardt Disease , Macular Degeneration Treated With , Mutation Agnostic Optogenetic Therapy , Week Results From , Clinical Trial , Pediatric Ophthalmology , Inherited Eye , Cell Therapies , Superior Performance , Chief Scientific , Vivo Efficacy , Novel Multi Characteristic Opsin , Mouse Model , Leber Congenital , Vice President ,